학술논문
OA 09.06 A Phase Ib Trial of Savolitinib plus Gefitinib for Chinese Patients with EGFR-Mutant MET-Amplified Advanced NSCLC
Document Type
Abstract
Author
Source
In Journal of Thoracic Oncology November 2017 12(11) Supplement 2:S1769-S1769
Subject
Language
ISSN
1556-0864